Lamperd Less Lethal, Inc.
LLLI · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Revenue | $1 | $0 | $2 | $2 |
| % Growth | 249.1% | -84.3% | 17.3% | – |
| Cost of Goods Sold | $1 | -$0 | $2 | $1 |
| Gross Profit | $0 | $0 | $1 | $1 |
| % Margin | 14.9% | 109% | 29.9% | 40.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $24 | $20 | $21 | $17 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $24 | $20 | $21 | $17 |
| Operating Income | -$24 | -$20 | -$20 | -$16 |
| % Margin | -1,862.7% | -5,360.9% | -860.4% | -826.1% |
| Other Income/Exp. Net | -$0 | -$0 | -$0 | -$0 |
| Pre-Tax Income | -$24 | -$20 | -$20 | -$17 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$24 | -$20 | -$20 | -$17 |
| % Margin | -1,889.8% | -5,474.5% | -870.2% | -840.4% |
| EPS | -0 | -0 | -0 | -0 |
| % Growth | 0% | 0% | 0% | – |
| EPS Diluted | -0 | -0 | -0 | -0 |
| Weighted Avg Shares Out | 286,231 | 286,231 | 286,231 | 286,231 |
| Weighted Avg Shares Out Dil | 286,231 | 286,231 | 286,231 | 286,231 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$24 | -$20 | -$20 | -$16 |
| % Margin | -1,862.7% | -5,360.9% | -860.4% | -826.2% |